(Q61933130)
Statements
A Phase II, Randomized, Double-blind, Placebo-controlled Trial of Acyclovir for the Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viral Load and Mucosal Shedding in HIV-1, Herpes Simplex Virus, Type 2 (HSV-2) Co-Infected Women (English)
0 references
September 2006
0 references
January 2009
0 references
50
0 references
18 year
0 references